From the Guidelines
Yes, end-stage renal disease (ESRD) does make someone immunocompromised. Patients with ESRD experience immune dysfunction that affects both innate and adaptive immune responses, as evident from a study published in 2022 1. This immune dysregulation occurs through several mechanisms, including uremic toxin accumulation, chronic inflammation, malnutrition, and metabolic acidosis that develop as kidney function deteriorates. The dialysis process itself can further contribute to immune dysfunction through blood exposure to artificial membranes and repeated vascular access. Specifically, ESRD patients show impaired neutrophil function, decreased antigen-presenting cell activity, T-cell dysfunction, and B-cell abnormalities.
Some key points to consider in the management of ESRD patients include:
- They are more prone to infection with Covid-19 due to their regular or occasional dialysis sessions, where they are exposed to a densely populated environment with a high possibility of SARS-CoV-2 transmission 1.
- ESRD patients may present with atypical manifestations of SARS-CoV-2 infection, leading to a delay in diagnosing the disease 1.
- The risk of developing a severe or lethal SARS-CoV-2 infection is likely higher in this population, and vaccinating them early against Covid-19 is highly recommended 1.
- Although ESRD patients develop seroconversion following vaccination, they are well-established to achieve a less robust and perhaps less durable antibody response 1.
- A third or booster dose of vaccine would be necessary for these individuals to produce an optimal antibody response 1.
Healthcare providers should maintain vigilance for signs of infection in these patients, as symptoms may be atypical or muted, and infections can progress rapidly in this population. ESRD patients should receive appropriate vaccinations (including pneumococcal, influenza, hepatitis B, and COVID-19 vaccines), though they may need higher doses or additional boosters due to suboptimal immune responses. Other guidelines also support the notion that ESRD patients are immunocompromised and require special consideration for vaccination and infection prevention 2, 3, 4.
From the Research
Immunocompromised State in End-Stage Renal Disease
- End-stage renal disease (ESRD) is associated with a unique set of immune disorders, including both immune activation and immune suppression 5.
- Patients with ESRD are considered immunocompromised due to their impaired immune response, which increases their risk of infections and other complications 6, 7.
- The immune dysfunction in ESRD is characterized by a state of immunodepression, contributing to the high prevalence of infections, as well as immunoactivation resulting in inflammation that may contribute to cardiovascular disease 7.
Immune System Dysfunction
- The immune system dysfunction in ESRD is complex and involves disorders of both the innate and adaptive immune systems 5, 7.
- Uremia is associated with a state of immune dysfunction, which contributes to the high morbidity and mortality in ESRD patients 7.
- The immune system dysfunction in ESRD is also linked to chronic inflammation, which is a major determinant of "dialysis syndrome" and can lead to premature aging and tissue degeneration 5.
Clinical Implications
- The immunocompromised state of ESRD patients requires special consideration in terms of vaccination and prevention of infectious diseases 6, 8.
- Patients with ESRD should be vaccinated against seasonal influenza, tetanus, hepatitis B, human papillomavirus, and Streptococcus pneumoniae to reduce their risk of infections 8.
- The immune system dysfunction in ESRD also highlights the need for personalized immunosuppressive treatment in patients after renal transplantation to minimize the risk of rejection and other complications 9.